Stock Report

All about this stock under one free report Last Updated: 08-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Alzamend Neuro Inc (ALZN) Key Ratios

Stock Card factsheet share-fund-plan-icon

$1.66

up-down-arrow $-0.04 (-2.35%)

As on 04-Sep-2026 16:20EDT

Market cap

info icon

$8 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

10.8

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -- --
EBIT -30.63 -152.07 -94.96 12.15 -3.98
Net Profit -30.51 -151.87 -94.30 12.14 -23.52
EPS -- -- -- -- --
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsApr-26Apr-25Apr-24
EBIT-Margin info ----------
Net Margin info ---309,051.48------
Return on equity info -1,812.88-1,156.21-373.18-657.17-4,408.31
Return on Capital info -1,185.97-779.37-373.18-539.17-2,645.56
Return on Assets info -246.31-205.28-262.55-172.50-303.88
Debt to Equity (x) info ---------0.12

Profitability

View Detailed Peer Comparison

ROCE

-373.18

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Alzamend Neuro Inc (ALZN)
-373.18
-539.17
-2,645.56
-181.47
-157.48
Peer Median
--
--
--
--
--
ROE

-373.18

--

Profit after tax / Average Net worth * 100

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Alzamend Neuro Inc (ALZN)
-373.18
-657.17
-4,408.31
-181.47
-160.92
Peer Median
--
--
--
--
--
ROA

-262.55

--

Profit after tax / Average Total assets * 100

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Alzamend Neuro Inc (ALZN)
-262.55
-172.50
-303.88
-145.64
-141.86
Peer Median
--
--
--
--
--
Net Margin

--

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Alzamend Neuro Inc (ALZN)
--
--
--
--
-309,051.48
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

EBIT Growth

-94.93

--

Year on year growth in operating profit (EBIT)

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Alzamend Neuro Inc (ALZN)
-94.93
54.75
33.17
-20.75
-24.37
Peer Median
--
--
--
--
--
Net Profit Growth

-94.30

--

Year on year growth in profit after tax

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Alzamend Neuro Inc (ALZN)
-94.30
54.61
33.14
-20.35
-144.96
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Alzamend Neuro Inc (ALZN)
--
--
-0.12
--
--
Peer Median
--
--
--
--
--
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Alzamend Neuro Inc (ALZN)
--
--
-0.12
--
--
Peer Median
--
--
--
--
--
Current Ratio

1.31

--

Current Assets / Current Liabilities and Provisions

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Alzamend Neuro Inc (ALZN)
1.31
6.58
0.14
2.03
12.37
Peer Median
--
--
--
--
--
Quick Ratio

--

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Alzamend Neuro Inc (ALZN)
--
--
--
--
--
Peer Median
--
--
--
--
--
Interest Coverage

-1,324.33

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Alzamend Neuro Inc (ALZN)
-1,324.33
-249.42
-983.83
-1,930.98
-264.71
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Asset Turnover

--

--

Sales / Average Total Assets

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Alzamend Neuro Inc (ALZN)
--
--
--
--
--
Peer Median
--
--
--
--
--
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Alzamend Neuro Inc (ALZN)
--
12,812.62
20,858.20
31,931.05
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

EV/EBITDA

0.08

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Alzamend Neuro Inc (ALZN)
0.08
0.89
0.01
0.35
1.14
Peer Median
--
--
--
--
--
loading...
loading...